MedPath

Evaluation the effect of dexmedetomidine with bupivacaine on postoperative pai

Phase 2
Conditions
Pain.
Generalized pain NOS
R52.9
Registration Number
IRCT20160430027677N15
Lead Sponsor
Oroumia University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Aged 20-60 years old
American Society of Anesthesiologists physical status classification I
General anesthesia

Exclusion Criteria

History of cardiovascular disease
History of respiratory disease
History of renal disease
History of liver disease
Pregnancy
Allergy to the drugs studied
Contraindication of supraclavicular block
Coagulopathy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain. Timepoint: In recovery, 6, 12 and 24 hours after surgery. Method of measurement: Visual Analogue Scale.;Duration of the sensory block. Timepoint: From the onset of the sensory block until the onset of the first pain after surgery. Method of measurement: Pinprick.;Duration of the motor block. Timepoint: Since full paralysis of limb until complete restoration of limb movement. Method of measurement: Bromage scale.
Secondary Outcome Measures
NameTimeMethod
Mean Arterial Blood Pressure. Timepoint: During surgery. Method of measurement: None Invasive Blood Pressure.;Mean pulse Rate. Timepoint: During surgery. Method of measurement: Electrocardiogram.;Pentazocine consumption. Timepoint: After transferring the patient to the ward in the first 24 hours. Method of measurement: milligram.
© Copyright 2025. All Rights Reserved by MedPath